A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study.

Cohen SJ, O'Neil BH, Berlin J, Ames P, McKinley M, Horan J, Catalano PM, Davies A, Weekes CD, Leichman L
Cancer Chemother Pharmacol. 2016 77 (4): 693-701

PMID: 26886016 · DOI:10.1007/s00280-016-2981-2

MeSH Terms (11)

Aged Albumins Antineoplastic Combined Chemotherapy Protocols Deoxycytidine Erlotinib Hydrochloride Female Humans Male Middle Aged Paclitaxel Pancreatic Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: